Portal de Periódicos da CAPES

Impact of contact force technology on reducing the recurrence and major complications of atrial fibrillation ablation: A systematic review and meta-analysis

2017; KARE Publishing; Linguagem: Inglês

10.14744/anatoljcardiol.2016.7512

2149-2271

Baopeng Tang,

Botulinum Toxin and Related Neurological Disorders

Impact of contact force technology on reducing the recurrence and major complications of atrial fibrillation ablation: A systematic review and meta-analysis Contact force (CF) monitoring can be useful in accomplishing circumferential pulmonary vein (PV) isolation for atrial fibrillation (AF).This metaanalysis aimed to assess the efficacy and safety of a CF-sensing catheter in treating AF.Randomized controlled trials or non-randomized observational studies comparing AF ablation using CF-sensing or standard non-CF (NCF)-sensing catheters were identified from PubMed, EMBASE, Cochrane Library, Wanfang Data, and China National Knowledge Infrastructure (January 1, 1998-2016).A total of 19 studies were included.The primary efficacy endpoint was AF recurrence within 12 months, which significantly improved using CF-sensing catheters compared with using NCF-sensing catheters [31.1% vs. 40.5%;risk ratio (RR)=0.82;95% confidence interval (CI), 0.73-0.93;p<0.05].Further, the acute PV reconnection (10.1% vs. 24.2%;RR=0.45; 95% CI, 0.32-0.63;p<0.05) and incidence of major complications (1.8% vs. 3.1%; OR=0.59; 95% CI, 0.37-0.95;p<0.05) significantly improved using CF-sensing catheters compared with using NCF-sensing catheters.Procedure parameters such as procedure duration [mean difference (MD)=-28.35;95% CI, -39.54 to -17.16; p<0.05], ablation time (MD=-3.8;95% CI, -6.6 to -1.0; p<0.05), fluoroscopy duration (MD=-8.18;95% CI, -14.11 to -2.24; p<0.05), and radiation dose (standard MD=-0.75;95% CI, -1.32 to -0.18; p<0.05] significantly reduced using CF-sensing catheters.CF-sensing catheter ablation of AF can reduce the incidence of major complications and generate better outcomes compared with NCF-sensing catheters during the 12-month follow-up period.(